Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease
- Authors
- Jo, S-K; Bajwa, A.; Awad, A. S.; Lynch, K. R.; Okusa, M. D.
- Issue Date
- 6월-2008
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- FTY720; SEW2871; ischemia-reperfusion injury; acute kidney injury; sphingolipid; S1P
- Citation
- KIDNEY INTERNATIONAL, v.73, no.11, pp.1220 - 1230
- Indexed
- SCIE
SCOPUS
- Journal Title
- KIDNEY INTERNATIONAL
- Volume
- 73
- Number
- 11
- Start Page
- 1220
- End Page
- 1230
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/123412
- DOI
- 10.1038/ki.2008.34
- ISSN
- 0085-2538
- Abstract
- The major sphingolipid metabolite, sphingosine-1-phosphate (S1P), has important biological functions. S1P is the ligand for a family of five G-protein-coupled receptors with distinct signaling pathways that regulate angiogenesis, vascular maturation, immunity, chemotaxis, and other important biological pathways. Recently, clinical trials have targeted S1P receptors (S1PRs) for autoimmune diseases and transplantation and have generated considerable interest in developing additional, more selective compounds. This review summarizes current knowledge on the biology of S1P and S1PRs that forms the basis for future drug development and the treatment of kidney disease.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.